By 12 months post hematopoietic stem cell transplantation (HSCT), vasculitic skin lesions had healed, lung disease was stable, and inflammatory markers normalized, and cellular and humoral immunity reconstituted, including recovery of CD8<sup>+</sup> central memory T cells and IgG and IgA. Here, CD79A is linked to lung disorder.